neuroClues
neuroClues provides an eye movement recording platform that captures objective biomarkers to support neurological disorder diagnosis and monitoring in clinical practice.
neuroClues® is a CE-marked class IIa medical device that records eye movements to generate objective, reproducible, and quantified data for neurological assessment. The platform enables clinicians to support disease diagnosis and monitoring, with acquisition taking approximately 10 minutes and covered under a reimbursement code. It is trusted by neurologists and leading hospitals across Europe.
Key People
Pierre Daye - CTO, Founder
Antoine Pouppez - Co-Founder & CEO